Home » Topics » Conferences

Conferences
RSS

Potent, orally active, second-generation neuroimmunophilin from Guilford

Sep. 7, 1998

Candidate oral fibrinogen receptor antagonist presented by Uriach at ACS meeting

Sep. 7, 1998

Isoxazoline- and isoxazole-containing factor Xa inhibitors prepared by DuPont

Sep. 7, 1998

LLPGE1 evaluated in pilot study; findings will be applied to future studies

Sep. 4, 1998

Alprostadil alfadex is a promising treatment for ED

Sep. 4, 1998

DW-2282: active enantiomer of DW-2143 and potent antitumor agent

Sep. 4, 1998

Merck KGaA synthesizes new PDE V inhibitor with potential for treating ED

Sep. 4, 1998

Potent mixed delta/mu-opioid agonist identified by Glaxo Wellcome/Delta team

Sep. 4, 1998

Taisho discovers potent and selective CRF1 receptor antagonists with anxiolytic effects

Sep. 4, 1998

Omapatrilat effective therapy for patients with chronic heart failure

Sep. 4, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...